
Bristol-Myers Squibb is to expand access to its clinical trial data – but researchers’ requests will have to be approved …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

